Close Menu

NEW YORK (GenomeWeb) – Natera reported after the close of the market on Tuesday that its fourth quarter 2018 revenues grew 29 percent, beating Wall Street's expectations.

For the three months ended Dec. 31, 2018, Natera recognized $67.0 million in revenue compared to $52.0 million in Q4 2017. Analysts, on average, had anticipated Q4 2018 revenues of $64.0 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
30
Sponsored by
Mission Bio

This webinar will outline a project that performs large-scale and integrative single-cell genome and transcriptome profiling of pediatric acute lymphoblastic leukemia (ALL) cases at diagnosis, during drug treatment, and in case of relapse.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.